Evaluation of anti-cancer activity of a new nanocomposite compound against Ehrlich carcinoma transplanted in mice.

Iman Hesham El Khashab;

Abstract


Cancer is an inherently biological disease, in which cell replication one of the hallmarks of life—fails to be regulated by the usual mechanisms. Historically, chemistry has been one of the most effective tools for treating cancer: Chemotherapy— treatment


Other data

Title Evaluation of anti-cancer activity of a new nanocomposite compound against Ehrlich carcinoma transplanted in mice.
Other Titles تقييم النشاط المضاد للسرطان لٲحد المركبات الجديدة المحضرة بتكنولوجيا النانو ضد سرطان ارليخ المزروع فى الفئران.
Authors Iman Hesham El Khashab
Keywords Evaluation of anti-cancer activity of a new nanocomposite compound against Ehrlich carcinoma transplanted in mice.
Issue Date 2013
Description 
Cancer is an inherently biological disease, in which cell replication one of the hallmarks of life—fails to be regulated by the usual mechanisms. Historically, chemistry has been one of the most effective tools for treating cancer: Chemotherapy— treatment

Attached Files

File SizeFormat
123005G3141.pdf451.68 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.